Cipla Drug Patent Portfolio

Cipla owns 1 orange book drug protected by 2 US patents Given below is the list of Cipla's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7589106 Alcohol free formulation of argatroban 26 Sep, 2027
Active
US7687516 Alcohol free formulation of argatroban 26 Sep, 2027
Active


Given below is the list of recent legal activities going on the following drug patents of Cipla.

Activity Date Patent Number
Patent litigations
Email Notification 26 Jul, 2021 US7589106
Change in Power of Attorney (May Include Associate POA) 26 Jul, 2021 US7687516
Change in Power of Attorney (May Include Associate POA) 26 Jul, 2021 US7589106
Email Notification 26 Jul, 2021 US7687516
Correspondence Address Change 23 Jul, 2021 US7687516
Correspondence Address Change 23 Jul, 2021 US7589106
Payment of Maintenance Fee, 12th Year, Large Entity 02 Jul, 2021 US7687516
Payment of Maintenance Fee, 12th Year, Large Entity 16 Feb, 2021 US7589106
Payment of Maintenance Fee, 8th Year, Large Entity 28 Sep, 2017 US7687516
Email Notification 02 Nov, 2013 US7687516
Mail-Petition Decision - Granted 30 Oct, 2013 US7687516
Petition Decision - Granted 29 Oct, 2013 US7687516
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 28 Oct, 2013 US7687516
Petition Entered 24 Sep, 2013 US7687516
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 20 Feb, 2013 US7589106


Cipla's Family Patents

Cipla drugs have patent protection in a total of 5 countries. It has a significant patent presence in the US with 69.2% of its patents being US patents. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Cipla Drug List

Given below is the complete list of Cipla's drugs and the patents protecting them.


1. Argatroban In Sodium Chloride

Argatroban In Sodium Chloride is protected by 2 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7589106 Alcohol free formulation of argatroban 26 Sep, 2027
(2 years from now)
Active
US7687516 Alcohol free formulation of argatroban 26 Sep, 2027
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Argatroban In Sodium Chloride's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Cipla News

AstraZeneca and Merck introduce a new patent in their efforts to protect Lynparza from generic competition

21 Nov, 2024

Cipla's growth path may face obstacles in the near future, says report from Moneycontrol

30 Oct, 2024

Preview of Cipla's Second Quarter: Anticipated absence of significant US drug introductions and a strong prior year performance might limit profit growth

24 Oct, 2024

Report: U.S. Aims to Eliminate HIV Epidemic by 2034 in the HIV Drugs and Injectables Market

09 Aug, 2024

See More